Page last updated: 2024-09-04

vatalanib and Injury, Ischemia-Reperfusion

vatalanib has been researched along with Injury, Ischemia-Reperfusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agostini, HT; Drevs, J; Hansen, LL; Junker, B; Maier, P; Martin, G; Unsoeld, AS	1

Other Studies

1 other study(ies) available for vatalanib and Injury, Ischemia-Reperfusion

Article	Year
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:6 Topics: Animals; Animals, Newborn; Disease Models, Animal; Female; Injections; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Phthalazines; Protein Kinase Inhibitors; Pyridines; Reperfusion Injury; Retinal Neovascularization; Treatment Outcome; Vitreous Body	2005

Article

Year

Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:6

Topics: Animals; Animals, Newborn; Disease Models, Animal; Female; Injections; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Phthalazines; Protein Kinase Inhibitors; Pyridines; Reperfusion Injury; Retinal Neovascularization; Treatment Outcome; Vitreous Body

2005